Niederer Kraft Frey (NKF) advised Bain Capital and its affiliate Castello Bidco on the Swiss law aspects of Castello’s debut senior secured floating rate notes issuance of EUR 550 million due 2031, and its entry into a new EUR 100 million revolving credit facility. Under the terms of the transactions, EUR 350 million in proceeds […]
Advestra advised Zürcher Kantonalbank as agent, security agent and lender and the other syndicate banks as lenders on the CHF 155 million syndicated cred
Niederer Kraft Frey advised Luzerner Kantonalbank, acting as agent, and the syndicate of banks on all aspects regarding the amendment of the existing financing for Hochdorf Swiss Nutrition (HSN), in the context of AS Equity
Homburger advised Noema Pharma, a clinical-stage biotech company, on its successful closing of a Series B extension financing round with an investment from EQT Life Sciences, and with continued support from Jeito and Forbion, all
MME advised True Global Ventures, a global technology equity venture capital firm, as the lead investor in a USD 16.3 million financing round (FR) for Validation Cloud, a Web3 data and AI company. MME’s team
Niederer Kraft Frey (NKF) advised Alpiq Holding on a revolving credit facilities agreement with an international syndicate of banks as lenders and a revolving loan facility agreement with a syndicate of Swiss banks as lenders.
Homburger advised Alchemy US on the renewal of its credit financings. The firm entered into a term loan credit agreement with HPS Investment as a term loan agent. The firm also entered into an asset-based
Swiss biotech company Alentis Therapeutics has successfully closed a $181.4 million oversubscribed Series D financing round, supported by a syndicate of top-tier biotech investors. The financing will support the company to develop a deep pipeline of
Homburger served as legal advisor to UBS Switzerland AG and other syndicate banks in connection with the financing of Deutsche Private Equity’s (DPE) acquisition of IMPAG Group. UBS acted as mandated lead arranger, underwriter,
Homburger advised Elanco in Switzerland on any aspect of Swiss law within the transaction. The background On the 13th of August 2024, Elanco Animal Health and Elanco US entered into an incremental assumption agreement to obtain
